Jeff Stolte is the Managing Partner at Providence Ventures, where he joined in 2014 to launch the organization’s first. See sector focus and contact routes.
Jeff Stolte is the Managing Partner at Providence Ventures, where he joined in 2014 to launch the organization’s first venture capital fund and leads healthcare technology investments while managing fund operations. His investment thesis focuses exclusively on healthcare technology, targeting companies that can leverage Providence’s 51-hospital system expertise, with a geographic emphasis on the United States and particular access to the Pacific Northwest. Typical check sizes range from $15 million to $50 million, and Stolte often co-leads or participates in significant rounds, such as the $15 million Kno2 round and the $50 million DexCare Series B. Notable portfolio companies include Kno2, a data interoperability platform; DexCare, a capacity management platform spun off from Providence; Wildflower Health, a virtual care platform for women; and Protenus, a healthcare data compliance firm. Stolte serves as a Board Director at Kno2, Trilliant, Intelligent Retinal Imaging Systems (IRIS), SpineZone, and Ready, Set, Food!, demonstrating a hands-on approach to governance. A distinctive point of his strategy is providing active portfolio companies direct access to Pr
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Seattle.
Investors like Jeff Stolte · Full investor directory · Investor access · Company funding database